潘雪峰,高春芳.LncRNA PVT1与恶性肿瘤治疗的研究进展[J].肿瘤学杂志,2019,25(2):145-151. |
LncRNA PVT1与恶性肿瘤治疗的研究进展 |
Research Progress of LncRNA PVT1 in Cancer Therapy |
投稿时间:2017-12-06 |
DOI:10.11735/j.issn.1671-170X.2019.02.B013 |
|
|
中文关键词: 长链非编码RNA PVT1 肿瘤 治疗靶点 |
英文关键词:long non-coding RNA plasmacytoma variant translocation 1 neoplasm therapeutic target |
基金项目: |
|
摘要点击次数: 2617 |
全文下载次数: 468 |
中文摘要: |
摘 要:长链非编码RNA-PVT1(lncRNA PVT1)作为一种重要的致癌性非编码RNA在多种恶性肿瘤呈现高表达并提示不良预后,其通过影响肿瘤细胞的增殖、迁移、侵袭和凋亡促进肿瘤的发生发展。目前大量的研究表明lncRNA PVT1在多种肿瘤中具有致癌活性或驱动作用,比如以竞争性内源RNA或作为“分子海绵”负性调控肿瘤相关miRNA的表达促进肿瘤发生等,因此,基于lncRNA PVT1在肿瘤发病中的关键作用,进一步的深入研究有望为恶性肿瘤提供新的治疗靶点。 |
英文摘要: |
Abstract:LncRNA PVT1 is an important carcinogenic long non-coding RNA,and the high expression of lncRNA PVT1 in malignant tumors suggests a poor prognosis. LncRNA PVT1 can promote the tumorigenesis and development of cancers by affecting cell proliferation,migration,invasion and apoptosis. Accumulating evidence has indicated that lncRNA PVT1,as a competing endogenous RNA or a molecular sponge,negatively modulates miRNA expression to promote the cancer development. Based on the critical role of lncRNA PVT1 in the pathogenesis of cancers,further study would provide a novel therapeutic target for various cancers in the future. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |